Colon cancer is the second most common cause of cancer-related deaths. The APC protein has long been known for its critical role in preventing colorectal cancer. When APC is inactivated, the development of colorectal cancer ...
Apr 2, 2018
0
9
A research team led by Monica Bettencourt Dias, from Instituto Gulbenkian de Ciencia (IGC, Portugal), has discovered important features of cancer cells that may help clinicians fighting cancer. The researchers observed that ...
Mar 28, 2018
0
29
The International Journal of Cancer has just published the results of an experimental therapy tested on mice. The research achieved an 80 percent reduction in liver metastasis brought about by colon cancer. Nanoparticles ...
Mar 13, 2018
0
6
Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry. The enzyme appears to drive ...
Jan 26, 2018
0
23
Scientists led by Dr Chris Toseland of the University's School of Biosciences studied a protein called Myosin VI, a molecular motor which acts as a courier to transport other proteins within our cells. Myosin VI is highly ...
Dec 4, 2017
0
0
Medications that block enzymes belonging to the kinase family are among the most effective pharmaceuticals for targeted cancer therapies. Scientists at the German Cancer Consortium (DKTK) at the Technical University of Munich ...
Dec 1, 2017
0
1
Cancer researchers at the University of Bergen (UiB) in Norway have in the recent years experienced with hundreds of known drugs, to see how they influence cancer cells.
Nov 15, 2017
0
11
The effect of combining clinically used drugs for the treatment of colon cancer can vary widely depending on concentrations, ranging from cases where the drugs counteract each other to cases where they reinforce each other. ...
Nov 6, 2017
0
1
Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis. Research led by scientists at the Institut Pasteur and Inserm ...
Oct 25, 2017
0
2
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.
Oct 17, 2017
0
159
